OBJECTIVE: To evaluate the impact of body mass on recurrence and progression in @entity1 with Ta, T1 @entity150 . METHODS: Data from 469 @entity1 with Ta, T1 @entity150 who were treated with transurethral resection of @entity150 at our center during 2006-2014 were retrospectively studied. According to body mass index (BMI), @entity1 were divided into three groups: normal weight (BMI < 24 kg/m(2)), overweight (24 kg/m(2)  <= BMI < 28 kg/m(2)) and @entity28 (BMI >=  28 kg/m(2)). Clinicopathologic features were compared across groups. Kaplan-Meier curves and Cox proportional hazards regression analyses were employed to assess the association between body mass and oncologic outcomes. RESULTS: Compared with @entity1 with normal weight, overweight and @entity28 counterparts showed significantly shorter recurrence-free or progression-free survival. In multivariate analyses, being overweight was an independent factor for recurrence and @entity28 was for both recurrence and progression. The presence of @entity6 ( @entity6 ) was not a strong risk factor for the entire cohort, while it became a significant predictor for both recurrence and progression in the subgroup of overweight and @entity28 @entity1 . CONCLUSION: Excessive body mass seems to act as independent risk factors for worse oncologic outcomes of Ta, T1 @entity150 . Further studies should be carried out to elucidate the exact impact of @entity28 , @entity6 or even other @entity209 .

Impact of body mass on recurrence and progression in Chinese XXXX with Ta, T1 @entity150 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity6 :: ('MESH:D003920', 'Disease') :: ['DM', 'diabetes mellitus'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obese', 'obesity'] @entity150 :: ('MESH:D001749', 'Disease') :: ['bladder tumor', 'urothelial bladder cancer', 'bladder cancer'] @entity209 :: ('MESH:D008659', 'Disease') :: ['metabolic disorders']
@entity1 :: (9606,Species) :: ['patients']
